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Abstract
Introduction: Estimating ephedrine’s effect on animal’s locomotor activity and evaluation of cumin fruit 
essential oil (FEO) effect and mechanism of ephedrine-induced hyper-locomotion. 
Methods: A new protocol developed for evaluation of manic behavior induced by ephedrine in a dose and time 
dependent manner. Following the suppressive effects of cumin FEO on acquisition and expression of ephedrine 
induced manic behavior was examined. Furthermore, the effect of L-NAME on expression of manic behavior and 
effect of bicuculline on suppressive effects of cumin FEO was evaluated. 
Results: Ephedrine at the dose of 100 mg/kg (i.p.) in a five days protocol significantly increased the locomotor 
activity in mice. In addition, cumin FEO at the specific dose of 2% significantly suppressed the acquisition and 
expression of hyperactivity induced by ephedrine. L-NAME at doses of 30 (p<0.01) and 40 mg/kg (p<0.05) showed 
similar effects as cumin FEO at the dose of 2%. Bicuculline (as a GABAA antagonist) at the specific dose of 2 
mg/kg (p<0.01) could significantly reverse the suppressive effects of cumin at the dose of 2%. 
Conclusion: It could be concluded that cumin can suppress the manic behavior induced by ephedrine through 
the both previously suggested mechanisms of nitric oxide syntheses pathway and GABAergic system. 
Declaration of Interest: None. 
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Introduction1
Bipolar disorder is a psychiatric disorder 
characterized by intermittent periods of mania and 
depression (1). As many other psychiatric 
disorders (e.g. PTSD, depression) there are well-
established animal model protocols in order to 
evaluate the effect of a wide range of drugs on 
behavioral changes following this disorder. 
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Amphetamine (AMPH) was used for induction of 
acute mania (2,3). AMPH-like psycho-stimulants 
promote acute and long-term activity in 
monoaminergic neurons (4). Long-term 
administration of AMPH leads to changes in 
dopaminergic and serotonergic systems activity in 
brain (2,3). 
Ephedrine is a psycho-stimulant drug with wide 
range of effects on the nervous system. It has been 
suggested that ephedrine like amphetamine might 
act on adrenoceptors and dopamine receptors (5). 
Previously, considering stimulant properties of 
ephedrine it was used for treatment of narcolepsy. 
On the other hand, psychosis from therapeutic 
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doses of ephedrine and amphetamine has been 
observed in narcoleptic patients (6). In a more 
recent study, Meng et al. (1999) showed IV 
injection of ephedrine could increase locomotor 
activity in mice. They proposed that this effect 
could be justified by similar structure of ephedrine 
and methamphetamine (7). 
Cuminum cyminumL. (Apiaceae) is an annual 
herbaceous plant with 15-50 cm stalk growing in 
Iran and many other xerothermic regions of 
Middle East and South America. The plant has 
narrow feathery leaves, small white or pink flower 
and fruits, which each one contains a small 
rhombus green seeds. In Iranian folk medicine it 
is used for treatment of diarrhea, toothache and 
epilepsy (8,9). Previously Janahmadi et al. (2006) 
showed that cumin fruit essential oil (FEO) can 
inhibit the seizure induced by Pentylenetetrazol 
(PTZ) in F1 neurons of sub-esophageal ganglia in 
Helix aspersa (Iranian garden snail). In addition, 
before the above study Sayyah et al. (2002) 
studied the anticonvulsant effects of cumin FEO 
agonist seizure induced by PTZ and maximal 
electroshock (MES). They showed that cumin 
could suppress the seizure and reduce mortality 
induced by MES and PTZ. In a more recent study 
Haghparast et al. (2008) showed that cumin FEO 
significantly can attenuate the expression of 
morphine tolerance and dependence in dose-
dependent manner while this effect was less on 
the development (acquisition) of morphine 
tolerance and dependence in morphine-dependent 
mice. In addition, in another set of experiments 
Khatibi et al. (2008) showed that the cumin FEO 
can significantly attenuate both acquisition and 
expression of morphine induced conditioned place 
preference in male albino mice. Two major 
mechanisms were proposed to be involved in 
cumin FEO effect on animals behavior: GABA 
mechanism and NOS pathway (8,10). 
In the current study we investigated whether 
ephedrine could induce hyperlocomotor activity 
following long-term i.p. administration and the 
suppressive effects of cumin FEO on the 
hyperlocomotor activity induced by ephedrine 
was evaluated. In the follow up study two 
proposed mechanisms about the effect of cumin 
FEO, which are the GABA mechanism and NO 
mechanism, were tested. 
Methods
Fruits of cuminum cyminum were obtained from a 
local market. M. Kamalinejad authenticated the 
plant at the department of pharmacognosy, faculty 
of pharmacy, Shahid Beheshti University, M.C., 
Tehran, Iran. A voucher specimen (no. C-1456) 
was deposited in the herbarium of this 
department. The fruits were subjected to 
hydrodistillation for 4 h by using a Clevenger 
apparatus and produced 3% (v/w) yield. 
Animals Two hundred and sixteen adult male 
albino Wistar mice (Pasteur Institute, Tehran) 
weighing 18-30 g were used in these experiments. 
They were kept 8-10 per cage (45×30×15 cm) at a 
room controlled temperature (23 ±1ºC) and 
maintained on a 12-h light/dark cycle (light on 
07:00 h) with free access to the standard rodent 
breeding diet and tap water. Each animal was used 
only once and killed immediately after the 
experiment. All experiments were executed in 
accordance with the guide for the care and use of 
laboratory animals (National Institutes of Health 
Publication No. 80-23, revised 1996) and were 
approved by the research and ethics committee of 
Shahid Beheshti University of Medical Sciences. 
Locomotion testing apparatus A square 
(50*50×40) Plexiglas chamber was chosen 
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inorder to measure the of animal's locomotor 
activity. Animals were placed individually in the 
center of chamber and moved distance for each 
animal was recorded separately. 
Locomotion tracking apparatus. Animal 
displacement, the total distance moved (distance 
traveled) during 5 min, was recorded on the test 
day by ethovision software (Version 3.1), a video 
tracking system for automation of behavioral 
experiments (Nodes Information Technology, the 
Netherlands), using a 3CCD camera (Panasonic, 
Japan) placed two meters above the square 
chamber. 
In this experiment 40 mice displacement during 5 
minute was recorded by ethovision software and 
after that they received either saline (10 ml/kg; 
i.p.) or ephedrine (30,50,100 mg/kg;10 ml/kg; 
i.p.). This protocol was repeated seven days and 
the animal's displacement was recorded every 
morning before injection. Finally, the best day and 
dose of ephedrine for induction of hyperactivity 
was selected for further experiments. 
Dose-response effect of cumin FEO on expression 
of hyperactivity induced by ephedrine after 4 days 
of administration of ephedrine (100 mg/kg;10 
ml/kg; i.p.; one injection each day) 48 mice 
received cumin FEO (0.1,0.5,1,2%;5 ml/kg, i.p.) 
60 min before behavioral testing on fifth day. 
In this experiment 48 mice received cumin FEO 
(0.1,0.5,1,2%; 5 ml/kg, i.p.) 60 min before each 
injection of ephedrine (100 mg/kg;10 ml/kg; i.p.) 
during four days of protocol. 
In this phase 40 mice received either saline or 
bicuculline (0.5,1,2 mg/kg, i.p.) 30 min before 
injection of cumin FEO (2%,5 ml/kg, i.p.) 60 min 
before testing on 5th after 4 days of administration 
of ephedrine (100 mg/kg;10 ml/kg; i.p.), one 
injection in each day. Separate groups of animals 
received the above mentioned and 90 min later 
their locomotor activity was recorded during 5 
minute and their moved distance were compared 
to intact mice. Effect of L-NAME on expression of 
hyperactivity induced by ephedrine. 
In this phase 40 mice received either saline or L-
NAME (30, 40, 50 mg/kg, ip) 60 min before 
testing on 5th after 4 days of administration of 
ephedrine (100 mg/kg; 10 ml/kg; i.p.), one 
injection in each day. 
Results
Dose/time-response effect of ephedrine on 
locomotor activity 
Our findings reveal that during 7 days of 
described protocol, animals, which received 
ephedrine 100 mg/kg showed higher scores of 
locomotor activity (Fig 1). 
 
Fig 1. Locomotor activity after receiving different 
doses of ephedrine 
 
One-way ANOVA showed there is a significant 
difference between day one measure of locomotor 
activity and day 2 in two different doses of 50 
mg/kg (P<0.01) and 100 mg/kg (P<0.01). 
However, further analysis showed there is no 
significant difference between locomotor activity 
of day 2 and 3 in 50 mg/kg group (P>0.05). On 
the other hand, in 100 mg/kg group animals 
showed higher locomotor activity in days 3 
(P<0.01), 4 (P<0.05), and 5 (P<0.01), but not in 
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days 6 (P>0.05), and 7 (P>0.05) in comparison 
with their previous days. 
Considering observed data, it had been concluded 
that the dose of 100 mg/kg is the most appropriate 
dose for evaluating the effect of ephedrine on 
locomotor activity. While the 5th day of 
measurement showed significantly different data 
from all other days at this dose. 
Acquired data in this phase revealed that injection 
of cumin FEO (0.1,0.5,1 and 2%), in comparison 
with vehicle group which received Tween-80 
(0.5%), 60 min before testing on 5th day could 
significantly attenuate the hyperactivity induced 
by ephedrine (100 mg/kg) [f (5,47)=33.214, 
P<0.01]. Dunnett's multiple comparison tests 
showed that FEO only at the dose of 2% could 
significantly reverse the effect of ephedrine (Fig 
2). 
 
Fig 2. Effects of different doses of the fruit 
essential oil of cuminum cyminum on the 
expression of ephedrine-induced locomotor 
activity 
 
Analysis data in this part revealed that bicuculline 
(0.5, 1, and 2 mg/kg), in comparison with saline, 
significantly reversed the suppressive effect of 
cumin FEO (2%) on hyperactivity induced by 
ephedrine (100 mg/kg) during the described 
protocol [P<0.01]. Dunnett's multiple comparison 
tests showed that bicuculline only at the dose of 2 
mg/kg (p<0.01) could significantly reverse the 
suppressive effect of Cumin FEO (Fig 4). 
Fig 3. Effects of different doses of the fruit 
essential oil of cuminum cyminum on the 
acquisition of ephedrine-induced locomotor 
activity 
Results revealed administration of cumin FEO 
(0.1, 0.5, 1 and 2%) 60 min before each injection 
of ephedrine (100 mg/kg) during the described 
protocol can significantly attenuate the 
hyperactivity induced by ephedrine [P<0.01] as 
compared to vehicle group that received Tween-
80 (0.5%). Dunnett's multiple comparison tests 
showed that FEO only at the dose of 2% could 
significantly reverse the effect of ephedrine 
(Fig3). 
 
Fig 4. Effect of different doses of bicuculline on 
suppressive effect of cumin 
 
Injection of above-mentioned doses of bicuculline 
to intact mice did not induce any changes into 
animal's locomotor activity (data are not 
presented). 
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Effect of L-NAME on expression of hyperactivity 
induced by ephedrine 
Acquired data revealed that administration of L-
NAME (30,40,50 mg/kg) on the test day instead 
of cumin FEO (2%) injection, in comparison with 
control group, which received, saline, 
significantly attenuates the hyperactivity induced 
by ephedrine (100 mg/kg) (P<0.01). Dunnett's 
multiple comparison tests showed that L-NAME 
at the doses of 30 (p<0.01) and 40 mg/kg (p<0.05) 
significantly suppressed the effects of ephedrine 
(Fig 5).  
Sole administration of L-NAME (30,40,50 mg/kg) 
did not alter the animal locomotor activity. 
 
Fig 5. Effects of different doses of L-NAME on 
the expression of ephedrine-induced locomotor 
activity 
Conclusion
In the current study we investigated whether 
ephedrine can be used for induction of 
hyperactivity as a criterion for bipolar disorder. 
Our results show that ephedrine at the dose of 100 
mg/kg during a 5 day protocol can induce 
hyperactivity. In several previous researches, 
increase in locomotor activity during a specific 
period is considered as a criterion for manic 
behavior (Arban et al., 2005; Kita et al., 2000). In 
many of these researches amphetamine was used 
as a psycho-stimulant for induction of 
hyperactivity. Furthermore, Zarrindast (1981) 
showed that ephedrine affects adrenoceptors and 
dopamine receptors and this effect is similar to 
that of amphetamine. Considering similar effects 
of amphetamine and ephedrine on adrenoceptors 
and dopamine receptors and also hyperlocomotor 
activity induced by ephedrine and with due 
attention to the previous researches which 
hyperlocomotor activity induced by amphetamine 
was used as a criterion for induction of manic 
behavior, it could be concluded that the effect of 
ephedrine on induction of hyperlocomotor 
activity, during the described protocol could be 
considered as a criterion for manic behavior. 
Furthermore, in another set of experiments we 
investigated whether and how cumin FEO can 
affect hyperactivity induced by ephedrine. 
Acquired data in this phase revealed that cumin 
FEO at the specific dose of 2% can significantly 
suppress the acquisition and expression of 
ephedrine induced hyperactivity. Previously it had 
been proposed that cumin FEO affects through 
two putative mechanisms: GABA transmission 
system and nitric oxide synthase pathway (8).  
GABA is a neurotransmitter with inhibitory 
effects on central dopaminergic neurons (5). In 
addition, amphetamine and ephedrine affect 
central nervous system through dopamine 
receptors and this effect might lead to manic 
behavior in those animals, which are under the 
effects of these substances (5). On the other hand, 
previous researches revealed the anticonvulsant 
properties of cumin FEO (13,14). In a previous 
study Janahmadi et al. (2006) showed that 
administration of cumin FEO can inhibit the 
epileptic activity of F1 neurons of Helix aspersa 
(Iranian snail garden) induced by pentylentetrazol 
(PTZ). Also Sayyaah et al. (2002) previously 
indicated that the lethality and seizure induced by 
PTZ or maximal electroshock can be reduced by 
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i.p. injection of cumin FEO. They also showed 
that the seizure induced by PTZ could be 
prevented by administration of drugs enhancing 
the GABAreceptor mediated inhibitory 
transmission. In addition, previous studies showed 
that sodium valporate as an anticonvulsant mood 
stabilizer drug, which is useful in acute treatment 
of bipolar disorder (11,15). Since GABA is a 
neurotransmitter with inhibitory control over 
central dopaminergic neurons (5), and sodium 
valproate can enhance GABA transmission (16) in 
the central nervous system it could be concluded 
that this drug may attenuate locomotor activity 
through GABA related mechanisms (11). Overall, 
considering the antiepileptic properties of cumin 
FEO and also the anti-sensitization effects of 
anticonvulsant drugs that act through GABA 
transmission system (e.g. sodium valporate) on 
manic behavior, it could be concluded that cumin 
FEO inhibits the manic behavior induced by 
ephedrine through changes in GABAergic system 
and the results of 4th experiment provide enough 
evidence to support this hypothesis. In this 
experiment, bicuculline as a GABAA Antagonist 
reversed the suppressive effects of Cumin FEO on 
hyperactivity induced by ephedrine. 
On the other hand, another explanation about 
justifying the mechanism for the Cumin FEO 
properties is the pathway of Nitric oxide (NO) 
production by the nitric oxide synthase (NOS) (8). 
In a previous study Eroglu and Caglayan (1997) 
showed that intravenous administration of 
Methylene blue (a direct inhibitor of nitric oxide 
synthase) results in antidepressant effects which 
suggest this hypothesis that NOS-NO pathway is 
involved in antidepressant action of Methylene 
blue. On the other hand, previous studies showed 
that there are major constituents in Cuminum 
cyminum green seeds, such as gamma-terpinene, 
thujadien, paracymene, d-glucopyrano sides and 
linolool (17,18), which have inhibitory effects on 
NOS in different cells and tissues. For example, in 
various studies T-dglucopyr-anoside, which are 
found in cumin seeds (18) demonstrated an 
inhibitory action on NOS (19, 20&21). 
Considering inhibitory effects of cumin FEO 
constituents on NOS and also previous 
investigation on effect of NOS inhibition using 
methylene blue on bipolar disorder (22) it could 
be concluded that cumin FEO takes action on 
locomotor activity following long-term 
administration of ephedrine through NOS 
inhibition. Results from the 5th experiment showed 
that L-NAME as a NOS inhibitor can significantly 
reduce the locomotor activity following long-term 
administration of ephedrine. Along with these 
findings it had been shown that solely 
administration of LNAME does not affect 
animals' locomotor activity. It emphasis that 
observed results cannot be linked to the effect of 
L-NAME on animals' locomotor activity. These 
findings provide supports for hypothesis that 
cumin takes action through NO-NOS pathway. 
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